Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
01/16/2023 | MADRIGAL PHARMACEUTICALS, INC. | MDGL | Grant | Common Stock | 26.7k | $0.00 | $0 | | 01/16/2023 |
06/17/2022 | Prelude Therapeutics Inc | PRLD | Grant | Director Stock Option (Right to Buy) | 34.3k | $4.74 | $162.6k | | 06/17/2022 |
02/22/2022 | MADRIGAL PHARMACEUTICALS, INC. | MDGL | Grant | Stock Option (Right to Buy) | 70k | $87.09 | $6.1M | | 02/22/2022 |
07/21/2021 | ALEXION PHARMACEUTICALS, INC. | ALXN | Disposition | Common Stock, par value $.0001 per share | 12.8k | $0.00 | $0 | | 07/21/2021 |
06/18/2021 | Prelude Therapeutics Inc | PRLD | Grant | Director Stock Option (Right to Buy) | 23.3k | $31.02 | $724.1k | | 06/18/2021 |
05/20/2021 | ALEXION PHARMACEUTICALS, INC. | ALXN | Grant | Common Stock, par value $.0001 per share | 2k | $0.00 | $0 | | 05/20/2021 |
05/20/2021 | ALEXION PHARMACEUTICALS, INC. | ALXN | Grant | Common Stock, par value $.0001 per share | 533 | $0.00 | $0 | | 05/20/2021 |
02/22/2021 | MADRIGAL PHARMACEUTICALS, INC. | MDGL | Grant | Stock Option (Right to Buy) | 50k | $119.49 | $6M | | 02/22/2021 |
09/29/2020 | Prelude Therapeutics Inc | PRLD | Conversion | Common Stock | 295.8k | $0.00 | $0 | | 03/27/2020 |
09/29/2020 | Prelude Therapeutics Inc | PRLD | Conversion | Common Stock | 152.6k | $0.00 | $0 | | 03/27/2020 |
09/29/2020 | Prelude Therapeutics Inc | PRLD | Conversion | Series A Preferred Stock | 295.8k | $0.00 | $0 | | 03/27/2020 |
09/29/2020 | Prelude Therapeutics Inc | PRLD | Conversion | Series B Preferred Stock | 152.6k | $0.00 | $0 | | 03/27/2020 |
05/26/2020 | INCYTE CORP | INCY | Grant | Common Stock | 1.3k | $0.00 | $0 | | 05/26/2020 |
05/26/2020 | INCYTE CORP | INCY | Grant | Non-Qualified Stock Option (right to buy) | 10.5k | $98.68 | $1M | | 05/26/2020 |
05/14/2020 | ALEXION PHARMACEUTICALS, INC. | ALXN | Grant | Common Stock, par value $.0001 per share | 3.5k | $0.00 | $0 | | 05/14/2020 |
03/27/2020 | Prelude Therapeutics Inc | PRLD | Purchase | Series B Preferred Stock | 76.3k | $0.00 | $0 | | 03/27/2020 |
03/05/2020 | MADRIGAL PHARMACEUTICALS, INC. | MDGL | Grant | Stock Option (Right to Buy) | 50k | $91.79 | $4.6M | | 03/05/2020 |
08/06/2019 | INCYTE CORP | INCY | Sale | Common Stock | 77.9k | $82.20 | $6.4M | | 08/02/2019 |
08/06/2019 | INCYTE CORP | INCY | Exercise | Non-Qualified Stock Option (right to buy) | 77.9k | $18.32 | $1.4M | | 08/02/2019 |
08/02/2019 | INCYTE CORP | INCY | Exercise | Non-Qualified Stock Option (right to buy) | 22.1k | $18.32 | $404.2k | | 08/02/2019 |
08/02/2019 | INCYTE CORP | INCY | Sale | Common Stock | 22.1k | $84.41 | $1.9M | | 08/02/2019 |
05/15/2019 | ALEXION PHARMACEUTICALS, INC. | ALXN | Grant | Common Stock, par value $.0001 per share | 2.7k | $0.00 | $0 | | 05/15/2019 |
04/26/2019 | INCYTE CORP | INCY | Grant | Employee Stock Option (right to buy) | 12.5k | $75.03 | $935.8k | | 04/26/2019 |
04/26/2019 | INCYTE CORP | INCY | Grant | Common Stock | 1.5k | $0.00 | $0 | | 04/26/2019 |
03/07/2019 | MADRIGAL PHARMACEUTICALS, INC. | MDGL | Grant | Stock Option (Right to Buy) | 50k | $127.96 | $6.4M | | 03/07/2019 |
11/20/2018 | MADRIGAL PHARMACEUTICALS, INC. | MDGL | Purchase | Common Stock | 4k | $117.88 | $471.5k | | 11/20/2018 |
11/19/2018 | MADRIGAL PHARMACEUTICALS, INC. | MDGL | Purchase | Common Stock | 4k | $124.00 | $496k | | 11/19/2018 |
06/11/2018 | MADRIGAL PHARMACEUTICALS, INC. | MDGL | Sale | Common Stock | 73.5k | $287.46 | $21.1M | By SQN LLC | 06/11/2018 |
05/09/2018 | ALEXION PHARMACEUTICALS, INC. | ALXN | Grant | Common Stock, par value $.0001 per share | 2.2k | $0.00 | $0 | | 05/09/2018 |
05/01/2018 | INCYTE CORP | INCY | Grant | Non-Qualified Stock Options (right to buy) | 15k | $60.85 | $912.8k | | 05/01/2018 |
03/01/2018 | MADRIGAL PHARMACEUTICALS, INC. | MDGL | Grant | Stock Option (Right to Buy) | 50k | $124.45 | $6.2M | | 03/01/2018 |
11/29/2017 | ALEXION PHARMACEUTICALS, INC. | ALXN | Grant | Common Stock, par value $.0001 per share | 2k | $0.00 | $0 | | 11/29/2017 |
11/16/2017 | INCYTE CORP | INCY | Sale | Common Stock | 28.5k | $105.24 | $3M | | 11/16/2017 |
05/26/2017 | INCYTE CORP | INCY | Grant | Non-Qualified Stock Options (right to buy) | 15k | $134.38 | $2M | | 05/26/2017 |
04/03/2017 | Dare Bioscience, Inc. | DARE | Grant | Common Stock | 10.3k | $0.73 | $7.5k | | 04/03/2017 |
|